van Neerven, Sanne M. http://orcid.org/0000-0003-2599-5756
Vermeulen, Louis http://orcid.org/0000-0002-6066-789X
Article History
Accepted: 24 August 2022
First Online: 29 September 2022
Competing interests
: L.V. received consultancy fees from Bayer, MSD, Genentech, Servier, and Pierre Fabre, but these had no relation to the content of this publication. S.M.v.N. declares no competing interests.